A pharmaceutical company uses an AI model to predict toxicity of a drug candidate. Because the prediction will directly influence a major development decision, the company performs extensive validation and establishes appropriate risk-mitigation measures. Statement I: The company's approach is consistent with the risk-based approach recommended for AI in drug development. Statement II: The extent of validation, risk mitigation and oversight should be proportionate to the context of use and the determined model risk.
Asked in GPSC Senior Drugs Inspector, Class-2 2026
Answer under review: our editors are checking this question. Try the other GPSC Prelims previous year questions questions meanwhile.
More GPSC Prelims previous year questions questions
- An AI model is used to identify potential drug-drug interactions. After deployment, the underlying data sources and clinical environment change substantially. The company continues to use the model without monitoring its performance or reassessing potential risks. Statement I: The company's approach is consistent with the principle of life-cycle management because the model has already been validated before deployment. Statement II: Good AI practice requires appropriate management of AI technologies throughout their lifecycle, including monitoring and addressing changes that may affect performance or risk.
- Statement I: The pKa can have a pronounced effect on the pharmacokinetics of the drug. Statement II: In general, drugs in an unionized form will tend to distribute throughout the body more rapidly than that with ionized molecules.
- Statement I: Potency and anti-inflammatory activity of ibuprofen is lower than that of other NSAIDs that contain two conjugated aromatic moieties. Statement II: Ibuprofen has only one aromatic ring.
- Statement I: Repaglinide possesses a basic benzoic acid structure. Statement II: The chemical structure of repaglinide is different from sulfonylureas.
- Statement I: Gentamicin is used for urinary tract infections, burns, some pneumonias, bone and joint infections. Statement II: Gentamicin is primarily effective against susceptible Gram-positive bacteria and is therefore used in the infections caused by these organisms.
- Statement I: Antifungal chemotherapy depends on biochemical differences between fungi and mammals. Statement II: Both fungi and mammals are eukaryotes, and the biochemical differences between them are not as great as one might expect. At the cellular level, the greatest difference between fungal cells and mammalian cells is that fungal cells have cell walls but the mammalian cells do not.
- Statement I: Primaquine and chloroquine are 8-aminoquinoline derivatives. Statement II: Primaquine is effective against the liver stage, whereas chloroquine is effective against the blood stage of the disease.
- Which of the following statements are correct regarding the study that led to the Nobel Prize in Physiology or Medicine being awarded to Svante Pääbo? I) The research showed that modern humans interbred with archaic groups such as Homo erectus and Neanderthals. II) The research proved that Neanderthals are direct ancestors of modern humans. III) Svante Pääbo succeeded in sequencing the genome of the Neanderthal